The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta

$37,727,154

Department of Health and Human Services·National Institutes of Health

to LEIDOS BIOMEDICAL RESEARCH INC

biotechactive
ACTION DATE·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75N91020F00030_7529_75N91019D00024_7529
Award description

CPTAC BIOSPECIMEN COLLECTION

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high
In plain English

Funds biospecimen collection and management for the Clinical Proteomic Tumor Analysis Consortium research program.

Sub-sectors
clinical-researchbiospecimenscancer-research
Why this matters

CPTAC advances precision medicine by enabling large-scale proteomic analysis of cancer tissues, supporting development of diagnostic and therapeutic tools.

Supply-chain signal

Drives demand for biospecimen processing, storage, and laboratory infrastructure services from clinical and research institutions.

U.S.–China competition angle

Strengthens U.S. cancer research capabilities and precision medicine leadership against international competitors in proteomics-driven drug development.

Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-14. Cost: $0.001342.

Period of performance
Start
2020-08-31
End
2027-08-30
Status
activein 473 days
Sources

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.